
Exact Sciences Corporation EXAS
€ 87.69
0.35%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Exact Sciences Corporation DSO 2011-2026 | EXAS
DSO Jährlich Exact Sciences Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.9 | 26.4 | 32.8 | 46.5 | 44.5 | 54.4 | 35.5 | 36.3 | 31.3 | 45.7 | 279 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 279 | 26.4 | 60.2 |
DSO Vierteljährlich Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.4 | 35.6 | 34.1 | - | 34 | 32.9 | 31.8 | - | 27.4 | 26.5 | 25.9 | - | 16.5 | 18 | 39.6 | 44.9 | 47.6 | 50.6 | 55.5 | 45.6 | 52.1 | 79.1 | 47.7 | 40.3 | 54.5 | 59.7 | 49.5 | 28.9 | 35 | 39.7 | 35.7 | 27.6 | 33.2 | 41.8 | 33 | - | - | - | - | - | 35.6 | 55.4 | 67.5 | - | 427 | 427 | 214 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 427 | 16.5 | 65.4 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 23.35 | -0.21 % | $ 251 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.59 | -0.94 % | $ 2.02 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Danaher Corporation
DHR
|
57 | $ 235.37 | 0.14 % | $ 172 B | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 12.04 | -6.67 % | $ 342 M | ||
|
Co-Diagnostics
CODX
|
101 | $ 6.09 | -0.49 % | $ 179 M | ||
|
DexCom
DXCM
|
85 | $ 67.79 | -0.94 % | $ 26.2 B | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 39.08 | -2.03 % | $ 1.09 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 17.15 | -0.44 % | $ 922 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.42 | - | $ 109 K | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 27.97 | 0.29 % | $ 846 M | ||
|
IQVIA Holdings
IQV
|
78 | $ 245.35 | 0.9 % | $ 44.5 B | ||
|
RadNet
RDNT
|
34.9 | $ 78.75 | 0.47 % | $ 5.75 B | ||
|
Guardant Health
GH
|
49.2 | $ 107.06 | -1.54 % | $ 13.1 B | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 141.04 | -3.29 % | $ 22.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 218.88 | 1.53 % | $ 11.2 B | ||
|
Natera
NTRA
|
81.5 | $ 234.3 | -2.2 % | $ 23.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 175.68 | -1.19 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
41.7 | $ 5.42 | -2.96 % | $ 703 M | ||
|
Pacific Biosciences of California
PACB
|
50.4 | $ 2.03 | -0.49 % | $ 515 M | ||
|
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 253.11 | -0.61 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 183.94 | -2.27 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
43.6 | $ 712.09 | -0.04 % | $ 58.7 B | ||
|
Lantheus Holdings
LNTH
|
72 | $ 66.5 | -2.0 % | $ 4.6 B | ||
|
Agilent Technologies
A
|
63.8 | $ 148.13 | 1.63 % | $ 45 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.74 | -4.79 % | $ 6.29 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | $ 48.1 | -0.72 % | $ 10.7 B | ||
|
Bioventus
BVS
|
92.3 | $ 7.86 | -1.75 % | $ 492 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
28.1 | $ 25.52 | 10.53 % | $ 33.1 M |